Related Experiment Video

Updated: Oct 6, 2026

The WinCF Model - An Inexpensive and Tractable Microcosm of a Mucus Plugged Bronchiole to Study the Microbiology of Lung Infections
06:57

The WinCF Model - An Inexpensive and Tractable Microcosm of a Mucus Plugged Bronchiole to Study the Microbiology of Lung Infections

Published on: May 8, 2017

[Diagnosis and management of cystic fibrosis in children]

A Tamalet1, B Fauroux, A Clement

  • 1Service de Pneumologie Pédiatrique, Hôpital Armand Trousseau, Paris, France.

Revue Des Maladies Respiratoires
|November 15, 2000
PubMed

Insights

Cystic fibrosis (CF) is a genetic disorder affecting multiple organs, primarily the lungs and pancreas. Early diagnosis and tailored treatments, including respiratory therapy and antibiotics, are crucial for improving patient outcomes and survival rates.

Area of Science:

  • Genetics and Molecular Biology
  • Pulmonology
  • Gastroenterology

Background:

  • Cystic fibrosis is a genetic disorder caused by mutations in the CFTR gene.
  • CFTR protein dysfunction leads to lung and pancreas complications.
  • Inflammation and microbial colonization characterize CF respiratory disease.

Purpose of the Study:

  • To review the pathophysiology and management of cystic fibrosis.
  • To highlight the importance of early diagnosis and current therapeutic strategies.
  • To discuss future perspectives for improving patient survival.

Main Methods:

  • Literature review of cystic fibrosis pathophysiology and treatment.
  • Analysis of current management guidelines for respiratory and pancreatic manifestations.
  • Evaluation of emerging therapeutic approaches.

Main Results:

  • CFTR protein dysfunction is central to CF pathogenesis.
  • Respiratory physical therapy and targeted antibiotics are key management components.
  • Nutritional support and pancreatic enzyme replacement are essential.

Conclusions:

  • Early diagnosis of cystic fibrosis is critical for optimal care and prognosis.
  • Multidisciplinary management involving respiratory, nutritional, and pharmacological interventions is necessary.
  • Advancements in understanding CF pathophysiology offer hope for improved survival.

More Related Videos

Generation of Human Nasal Epithelial Cell Spheroids for Individualized Cystic Fibrosis Transmembrane Conductance Regulator Study08:00

Generation of Human Nasal Epithelial Cell Spheroids for Individualized Cystic Fibrosis Transmembrane Conductance Regulator Study

Published on: April 11, 2018

Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis05:56

Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis

Published on: August 29, 2025

Related Concept Videos

Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment: